A HER2 Specific Nanobody–Drug Conjugate: Site-Selective Bioconjugation and In Vitro Evaluation in Breast Cancer Models.
Saved in:
| Title: | A HER2 Specific Nanobody–Drug Conjugate: Site-Selective Bioconjugation and In Vitro Evaluation in Breast Cancer Models. |
|---|---|
| Authors: | Hansen, Anders H.1 (AUTHOR) anders.hoejgaard.hansen@gmail.com, Andersen, Kasper I. H.2 (AUTHOR) claban@food.dtu.dk, Xin, Li3 (AUTHOR), Krigslund, Oliver4 (AUTHOR) niels.behrendt@finsenlab.dk, Behrendt, Niels4 (AUTHOR) lhe@finsenlab.dk, Engelholm, Lars H.4 (AUTHOR), Bang-Bertelsen, Claus H.2 (AUTHOR), Schoffelen, Sanne5 (AUTHOR), Qvortrup, Katrine1 (AUTHOR) kaqvo@kemi.dtu.dk |
| Source: | Molecules. Jan2025, Vol. 30 Issue 2, p391. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
